Principal Financial Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,455
Closed -$334K 2262
2015
Q3
$334K Buy
4,455
+564
+14% +$42.1K ﹤0.01% 1925
2015
Q2
$293K Buy
+3,891
New +$208K ﹤0.01% 1957

Principal Financial Group's KYTH Position: Q4 2015 in Review

Principal Financial Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 4,455 shares — an estimated $334K sold.

Principal Financial Group first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $334K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Principal Financial Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Principal Financial Group sold 4,455 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $334K.
  • Principal Financial Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Principal Financial Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $334K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Principal Financial Group's 13F filing for Q4 2015, filed 9 Feb 2016.